Fluke Biomedical, a leading manufacturer of biomedical test instruments, announced the acquisition of Unfors RaySafe. With this acquisition Fluke Biomedical adds devices for diagnostic X-ray from Unfors RaySafe to its portfolio to broaden its customer base. Fluke Biomedical aims to provide healthcare providers, institutions and medical device manufacturers with a complete portfolio of test equipment.
“The fact that our companies share a similar culture is an ideal basis for continuing our excellent relationships with our employees, customers and partners,” says Magnus Kristoferson, CEO, Unfors RaySafe. “We have experience in highly specialised markets all over the world, we know our business and we can now maximise our competencies. In the past, Unfors RaySafe has attracted the attention of the market not just for the functionality and measurement accuracy of its products, but also for the attractive design and intuitive user interface,” he added.
Fluke Biomedical General Manager, Eric Conley says, “The acquisition of Unfors RaySafe brings to Fluke Biomedical a strong team that has delivered leading innovation to the radiation test and safety markets. The combination of Unfors RaySafe and Fluke Biomedical accelerates our ability to provide a broad portfolio of world class test equipment to our customers.” With worldwide sales and distribution channels, Fluke Biomedical anticipates growth through innovative design and creative solutions for their customers.
EH News Bureau
- Advertisement -
